Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections

Area of Science:

• Transplantation Medicine
• Infectious Diseases
• Microbiology

Background:

• Liver transplant (LT) recipients are highly susceptible to multidrug-resistant (MDR) pathogens.
• Ubiquitous risk factors for colonization and infection are inherent to the transplantation process.
• Advances have reduced methicillin-resistant Staphylococcus aureus infections, but vancomycin-resistant enterococci and gram-negative bacilli remain critical issues.

Purpose of the Study:

• To review the challenges and current status of multidrug-resistant pathogen infections in liver transplant recipients.
• To highlight the persistent threat posed by gram-negative bacilli despite new antibiotic development.

Main Methods:

• Review of current literature and clinical challenges in managing MDR infections post-liver transplantation.
• Analysis of trends in resistant pathogen incidence and impact on morbidity and mortality.

Main Results:

• Decreased incidence of methicillin-resistant Staphylococcus aureus infections in LT recipients.
• Persistent high rates of morbidity and mortality associated with vancomycin-resistant enterococci and gram-negative bacilli.
• Lack of a universal agent for effective treatment of MDR gram-negative infections.

Conclusions:

• Multidrug-resistant gram-negative infections continue to be a major concern in liver transplantation.
• Effective prevention and treatment necessitate a collaborative, multidisciplinary approach.
• Ongoing research is crucial for developing rapid diagnostics and novel antibiotics to combat MDR organisms.